Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.275    0.035 (14.58%)
Bid:
0.26
Ask:
0.29
Spread: 0.03 (11.538%)
Market Cap: £15.94m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Chairman’s AGM Statement

3 Nov 2022 07:00

RNS Number : 1446F
CAP-XX Limited
03 November 2022
 

 

 

3 November 2022

 

CAP-XX Limited

("CAP-XX" or the "Company")

 

Chairman's AGM Statement

 

CAP-XX Limited, a world leader in the design and manufacture of supercapacitors and energy management systems, announces that at the Company's Annual General Meeting to be held later today, CAP-XX's Chairman will make the following statement in relation to the Company's activities:

 

"As reported in the Company's announcement on 29 September this year, the full year results for the last financial year demonstrated a very strong growth in sales, with product sales up 44% and Gross Margin up 43%.

 

We also indicated that the current financial year has started somewhat slower than expected due to several influences including: industry wide supply chain bottlenecks, especially in China, a global shortage of integrated circuits and increasing pessimism over the state of the global economy. However, we remain optimistic about the short term and long term growth prospects of the Company. Despite the slower than expected start to the year, there are indications that the order book is starting to bounce back and our outlook for full year revenue and adjusted EBITDA for the year ending 30 June 2023 remains in line with market expectations.

 

Sales of the new products manufactured at Seven Hills continue to grow strongly and we remain confident that over 75% by value of the former Murata customers will be retained. I am pleased to add that we are now shipping the first of the Ioxus modules, for a ship propulsion project, which has the potential to make a significant contribution this year and next.

 

Longer term, we are buoyed by the knowledge that our total known sales opportunities (what we refer to as our sales pipeline) remain in excess of US$60m p.a. and without any significant contribution yet from some of the new product families we have recently launched, such as the Lithium-ion capacitors, Truck Start and large cylindrical modules and cells.

 

Operations continue to improve, especially at Seven Hills where yield continues to improve along with gross margin and where we have the ability to increase DMF and DMT production by a factor of four.

 

The Company continues to carefully control all operating expenses and discretionary costs to ensure we get to a position of positive cashflow as soon as possible. Cash reserves at 30 June 2022 were A$1.6m with another approximately A$2.0m in relation to a R&D tax rebate expected this calendar year, in line with earlier estimates.

 

Finally, we continue to review the Company's Board structure. We are delighted with Steen Feldskov's recent appointment as a non-executive director. Mr Feldskov is already making a great contribution, especially in relation to making introductions to broaden the Company's distribution channels. The Board will continue to look for additional non-executive directors who can make a strong contribution to the Company."

 

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

 

Allenby Capital (Nominated Adviser and Joint Broker)

David Hart / Alex Brearley (Corporate Finance) +44 (0) 20 3328 5656

Tony Quirke (Equity Sales)

 

Cenkos Securities plc (Joint Broker)

Neil McDonald / Pete Lynch

 

+44 (0) 13 1220 6939

 

More information is available at www.cap-xx.com

 

 

Notes to Editors:

 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high-power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMUPGRUGUPPPPP
Date   Source Headline
2nd Jul 20197:00 amRNSUS court action settlement and licence agreement
25th Jun 201910:45 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jun 20198:59 amRNSHolding(s) in Company
6th Jun 20199:03 amRNSTrading Update
30th May 20198:27 amRNSHolding(s) in Company
17th Apr 20193:09 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSTrading Update
6th Mar 20197:00 amRNSInterim Results
1st Mar 20197:36 amRNSDirector Disclosure Update
22nd Jan 20198:32 amRNSHolding(s) in Company
20th Dec 20188:43 amRNSIssue of Shares and Director/PDMR Shareholdings
20th Nov 20188:29 amRNSResult of AGM and Chairman's AGM statement
14th Nov 20187:00 amRNSHolding(s) in Company
5th Nov 20187:00 amRNSSubscription to raise £1.75 million
23rd Oct 20187:00 amRNSExercise of share options & PDMR shareholding
22nd Oct 201810:09 amRNSNotice of AGM
17th Oct 20187:00 amRNSAudited results for the year ended 30 June 2018
8th Oct 20182:05 pmRNSSecond Price Monitoring Extn
8th Oct 20182:00 pmRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSNew licence agreement with TDK
5th Oct 20188:00 amRNSNotice of Results
25th Sep 201810:22 amRNSSpire Health Tags launched in Apple stores
18th Jul 20188:30 amRNSDirector/PDMR Shareholding
13th Jul 20187:00 amRNSExercise of share options
22nd Jun 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
21st Jun 20187:00 amRNSExercise of share options & PDMR shareholding
20th Jun 20187:00 amRNSTrading update
1st May 20187:00 amRNSExercise of employee share options
11th Apr 20187:00 amRNSDeveloping first 3V thin prismatic supercapacitors
6th Mar 20182:25 pmRNSInterim Results (Replacement)
6th Mar 20187:00 amRNSInterim Results
15th Feb 20188:46 amRNSNotice of results
16th Jan 20187:00 amRNSHolding(s) in Company
18th Dec 201711:42 amRNSGrant of Share Options
12th Dec 201710:35 amRNSIssue of Shares and Director/PDMR Shareholdings
23rd Nov 20179:40 amRNSResult of AGM and Chairman's AGM statement
20th Nov 20177:00 amRNSSpire launches Thinline enabled wearable
30th Oct 20177:00 amRNSNotice of AGM
9th Oct 20177:00 amRNSAudited results for the year ended 30 June 2017
22nd Sep 20178:59 amRNSHolding(s) in Company
22nd Sep 20177:00 amRNSNotice of Results
23rd Aug 20178:37 amRNSHolding(s) in Company
15th Aug 20177:00 amRNSFirst high-volume order for Thinline
29th Jun 20178:22 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jun 20177:00 amRNSTrading update for year ending 30 June 2017
25th May 20178:51 amRNSExtension of option term and Director/PDMR dealing
19th Apr 20178:47 amRNSHolding(s) in Company
20th Mar 20177:00 amRNSInterim Results
9th Mar 20177:00 amRNSCAP-XX launches new cylindrical supercapacitors
1st Feb 20177:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.